Bridgeway Capital Management
BVS icon

Bridgeway Capital Management’s Bioventus BVS Stock Holding History

Bridgeway Capital Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-313,804
Closed -$1.8M – 1264
2024
Q2 		$1.8M Hold
313,804
– – 0.04% 539
2024
Q1 		$1.63M Sell
313,804
-50,000
-14% -$244K 0.03% 629
2023
Q4 		$1.92M Hold
363,804
– – 0.04% 601
2023
Q3 		$1.2M Hold
363,804
– – 0.03% 658
2023
Q2 		$1.05M Buy
363,804
+61,395
+20% +$118K 0.03% 718
2023
Q1 		$324K Buy
302,409
+151,105
+100% +$289K 0.01% 987
2022
Q4 		$395K Buy
+151,304
New +$661K 0.01% 942

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bridgeway Capital Management's BVS Position: Q3 2024 in Review

Bridgeway Capital Management sold out of Bioventus (BVS) in Q3 2024, closing a stake of 313,804 shares — an estimated $1.8M sold.

Bridgeway Capital Management first reported a position in BVS in Q4 2022 and held it in 7 quarters. The position peaked at $1.92M in Q4 2023. 138 funds tracked by Wall St. Rank hold BVS as of Q3 2024.

  • Bridgeway Capital Management reported no remaining Bioventus position as of Q3 2024 after selling out during the quarter.
  • Bridgeway Capital Management sold 313,804 Bioventus shares in Q3 2024, an estimated $1.8M.
  • Bridgeway Capital Management first reported a position in Bioventus in Q4 2022 and held it in 7 quarters.
  • Bridgeway Capital Management's Bioventus position peaked at $1.92M in Q4 2023.
  • 138 funds tracked by Wall St. Rank held Bioventus as of Q3 2024.

Based on Bridgeway Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.